Bioceres Crop Solutions (NASDAQ:BIOX) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPS

Bioceres Crop Solutions (NASDAQ:BIOX) announced its quarterly earnings results on Monday. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11), Zacks reports. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The firm had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same period last year, the firm posted ($0.07) EPS.

Bioceres Crop Solutions Price Performance

Bioceres Crop Solutions stock traded up $0.50 during midday trading on Wednesday, hitting $7.16. The company’s stock had a trading volume of 383,668 shares, compared to its average volume of 87,848. The company has a quick ratio of 0.86, a current ratio of 1.24 and a debt-to-equity ratio of 0.35. The stock’s 50-day moving average price is $7.73 and its 200-day moving average price is $9.85. Bioceres Crop Solutions has a 12 month low of $5.71 and a 12 month high of $14.05. The company has a market capitalization of $450.01 million, a PE ratio of 360.68 and a beta of 0.49.

Wall Street Analysts Forecast Growth

BIOX has been the subject of several analyst reports. Roth Mkm reduced their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Canaccord Genuity Group reduced their price objective on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a report on Wednesday. Lake Street Capital reduced their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, September 11th. Finally, Oppenheimer reduced their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, October 21st. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, Bioceres Crop Solutions currently has a consensus rating of “Buy” and an average price target of $12.13.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.